Humana stock

HUM · NYSE · USD

Compare Humana
$450.00Change from previous close: +1.42%Absolute change: +$6.32

Close · November 13, 2026

Price history

+90.08% over the period

1 year: from $236.74 (November 13, 2025) to $450.00 (November 13, 2026), +90.08%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 13, 2026$450.00
October 30, 2026$414.50
September 30, 2026$381.57
August 31, 2026$383.23
July 31, 2026$363.86
June 30, 2026$397.22
May 29, 2026$305.42
April 30, 2026$236.44
March 31, 2026$173.39
February 27, 2026$190.54
January 30, 2026$195.20
December 31, 2025$256.13
November 28, 2025$245.77
November 13, 2025$236.74

At a glance

  • The company

    Offers Medicare Advantage, prescription drug plans, specialty insurance and healthcare services to senior populations in the United States

  • Latest results

    Quarter to September 30, 2026 · EPS -$0.70 (estimate -$1.00)

TickerLandia's take on Humana

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$163.11
52-wk high$456.50

−1.42% from the 52-week high

Analysts · 26 analysts

Average target$465.13+3.36% vs. price

Buy 16 · Hold 9 · Sell 1 · Buy

TickerLandia Fingerprint: Humana

Compared with similar companies: very strong momentum and very low profitability.

Financials and price compared with 44 companies in related industries (health_services), worldwide. Momentum and risk compared with 883 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Humana is pricier than in the past and pricier than similar companies

On the latest fiscal year's earnings (2025), Humana's P/E today is 45.7, above the median of its last 10 fiscal years (23.0; between 14.8 and 50.1 from 2016 to 2025). Humana's P/E (trailing 12 months): 39.0, +114% against the median of a group of 7 similar companies (18.3).

P/E compared with its history

Compared with 7 similar companies

Humana's metrics compared with similar companies
MetricHumanaPosition in the groupBand
P/E (trailing 12 months)39.0High
Forward P/E26.7High
Operating margin2.3%Low
ROE6.9%Low
Debt/equity0.76High

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Humana. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$40.87B

Latest quarter · Q2 2026

Net income

$694M

Latest quarter · Q2 2026

Quarterly net margin

1.7%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
$50.12B
P/E
39.0
EPS
$10.28
Volume
65.01K
Daily trading
€606.42M
Dividend yield
0.79%

How Humana is changing

All results
  • Revenue grew 10.9% a year on average over the last 5 years

  • Operating margin fell from 4.1% to 2.1%

  • Profits turn into cash: free cash flow equal to 118% of net income

Returns

Humana returns with dividends

$1,000 invested in Humana 5 years ago, on November 15, 2021, would be worth $1,080 today with dividends reinvested: +8.00% in total, +1.55% per year. On price alone it would be $1,027 (+2.70%).

PeriodHumanaS&P 500$1,000 becomes
1 month+7.05%−3.12%$1,070
6 months+47.61%+1.58%$1,476
Year to date+75.69%+10.46%$1,757
1 year+92.58%+12.23%$1,926
3 years−6.11%+71.41%$939
5 years+8.00%+61.48%$1,080
10 years+146.38%+249.40%$2,464

Over the last 6 months it has done better than 85% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment

The chart in detail

Humana: technical analysis

Humana is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 20.1% below its highest close since January 2, 1990 ($563.00, November 3, 2022).

Trend
Upward
RSI (14 sessions)
64
Between 30 and 70
vs 200-session average
+41.80%

Support and resistance

Price areas where Humana has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. No resistance above: the price is near the highs of the year
  2. Last price$450.00
  3. Support$416.18−7.52%3 touches, last on September 25, 2026
  4. Support$403.43−10.35%2 touches, last on November 2, 2026
  5. Support$389.35−13.48%2 touches, last on August 10, 2026

Volatility and risk

Over the last year it has moved less than the S&P 500.

Beta (1 year) vs S&P 500
0.54
Volatility (60 sessions, annualised)
37.8%
Largest fall in the last year
−42.36%

Close of November 13, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Humana: seasonality

Average monthly price change over 37 years

+0.2%Jan−1.1%Feb−2.2%Mar+2.2%Apr+4.3%May−0.3%Jun+1.9%Jul+2.6%Aug+0.8%Sep+2.0%Oct+2.8%Nov+2.5%Dec

Over the last 37 years, the strongest month for Humana has been May: +4.35% on average, positive in 23 years out of 37. The weakest has been March: −2.21% on average, positive in 17 years out of 37. November, the current month, has been positive in 22 years out of 36 (+2.79% on average).

Show chart data
MonthAverageMedianPositive years
January+0.24%+1.01%21 of 36
February−1.12%−2.39%12 of 37
March−2.21%−1.03%17 of 37
April+2.20%+1.02%20 of 37
May+4.35%+4.63%23 of 37
June−0.31%+1.65%23 of 37
July+1.87%+2.17%23 of 37
August+2.59%+4.10%25 of 37
September+0.76%+0.71%21 of 37
October+2.01%+3.17%20 of 37
November+2.79%+2.47%22 of 36
December+2.51%+0.89%19 of 36

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Humana and its competitors

Humana's sales are concentrated in the United States, where it sells medical and specialty insurance products. Its Insurance segment centers on Medicare Advantage plans, including wellness programs and chronic care management, along with stand-alone prescription drug plans, Medicare supplements, and dental, vision, life and disability coverage. The company also administers health care arrangements for military retirees and their dependents and runs pharmacy benefit management.

Headquarters
Louisville, United States
Employees
67,060
Founded
1961
Chief executive
James Rechtin
Humana and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
HumanaHUM$50.12B2.3%39.0+47.61%
Cigna GroupCI$78.26B3.8%13.1−1.23%
CenteneCNC$33.52B1.9%22.8+21.19%
Elevance HealthELV$92.88B4.0%18.3+7.52%
CVS HealthCVS$114.32B3.1%10.4−8.93%
UnitedHealth GroupUNH$365.09B5.9%23.3+1.57%

Same industry or related industries, similar size. Compare Humana with its competitors · Full profile